NEOGENOMICS INC (NEO)
$18.08-$0.56 (-3.00%) Today
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 30,614 | $440K |
| Grant or award | 18 | 240,221 | |
| Option exercise | 18 | 390,850 | |
| Tax withholding / forfeiture | 1 | 11,060 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
67 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Alicia C. Olivo - Officer | Tax withholding / forfeiture | Common Stock | 652 | $0.00 | - | |
 Anthony P. Zook - Officer | Grant or award | Stock Option (Right to Buy) | 729,927 | $0.00 | - | |
| Anthony P. Zook - Officer | Grant or award | Restricted Stock Unit | 421,496 | $0.00 | - | |
| Warren Stone - Officer | Grant or award | Stock Option (Right to Buy) | 94,518 | $0.00 | - | |
| Warren Stone - Officer | Grant or award | Restricted Stock Unit | 52,687 | $0.00 | - | |
 Jeffrey Scott Sherman - Officer | Tax withholding / forfeiture | Common Stock | 11,746 | $0.00 | - | |
| Warren Stone - Officer | Tax withholding / forfeiture | Common Stock | 6,224 | $0.00 | - | |
| Alicia C. Olivo - Officer | Open-market sale | Common Stock | 5,175 | $15.36 | $79K | |
| Felicia Williams - Director | Grant or award | Stock Option (Right to Buy) | 5,430 | $0.00 | - | |
| Felicia Williams - Director | Grant or award | Restricted Stock Unit | 7,160 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 67 NEO filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GREG AUNAN | Officer | 20,000 | $321K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
NEOGENOMICS INC (NEO) had 13 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for NEO runs to 67 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NEO were filed in the last 90 days. 10 purchases are on record for this company.
3 insider sales of NEO were filed in the last 90 days, totaling $440K.
This page tracks NEO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NEO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
